It is believed that these interesting findings may provide new insights on diabetic cardiomyopathy via the novel ncRNA-PDK4 axis through mediating mitochondrial quality control, oxidation metabolism, oxidative stress and inflammation. This evidence concerns the gene PDK4 and diabetic cardiomyopathy.